EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review

Dea Metko, Shanti Mehta iD, Cathryn Sibbald iD

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15691 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Dea Metko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada. Hauptthemen laut MEDLINE: Alopecia Areata, Dermatitis, Atopic, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our study aims to synthesize existing evidence of dupilumab for alopecia areata (AA) in pediatric patients with atopic dermatitis (AD). We searched MEDLINE and Embase on March 1, 2024, using keywords related to AD, AA, dupilumab, and pediatric patient populations per PRISMA‐ScR guidelines. A mean SALT score reduction of 42.6 following dupilumab treatment ( p < .01) over an average of 3.21 months, and a mean reduction of Investigator Global Assessment (IGA) levels of 2.14 units ( p < .01) demonstrates the efficacy of dupilumab in pediatric AA when there is concurrent AD. Our findings in combination with dupilumab's favorable safety profile in pediatric AD makes it an appealing option for AA treatment, however, a greater understanding of the underlying mechanisms, optimal pediatric patient selection criteria, long‐term efficacy, and safety profile of dupilumab in this context is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataDermatitis, AtopicAntibodies, Monoclonal, HumanizedHumansChildTreatment Outcome

Stichwörter der Autor:innen

alopecia areataatopic dermatitisdupilumabeczema

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Division of Pediatric Dermatology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

ORCID-Profile: Shanti Mehta, Cathryn Sibbald

Zitieren

APA

Metko, D., Mehta, S., & Sibbald, C. (2024). Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review. Pediatric Dermatology. https://doi.org/10.1111/pde.15691

Vancouver

Metko D, Mehta S, Sibbald C. Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review. Pediatric Dermatology. 2024. doi:10.1111/pde.15691

BibTeX
@article{Metko2024,
  author = {Metko, Dea and Mehta, Shanti and Sibbald, Cathryn},
  title = {Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15691}
}
Kostenlos starten →